Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.

International journal of hematology - 1 Sept 2020

Nonino Alexandre, Campregher Paulo Vidal, de Souza Santos Fabio Pires, Mazzeu Juliana Forte, Pereira Rinaldo Wellerson

Abstract excerpt

Genomic characterization of patients with myeloproliferative neoplasms (MPN) may lead to better diagnostic classification, prognostic assessment, and treatment decisions. These goals are particularly important in myelofibrosis (MF). We performed target Next Generation Sequencing for a panel of 255 genes and Chromosome Microarray Analysis (CMA) in 27 patients with MF. Patients were classified according to genomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium-Binding Proteins
Share to Calreticulin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Adhesion Molecules

Share to Janus Kinase 2

Share to Loss of Heterozygosity

Share to Microarray Analysis

Share to Myeloproliferative Disorders

Share to Primary Myelofibrosis

Source

Identifiers

PMID: 32535855
DOI: 10.1007/s12185-020-02906-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.PMID 32535855Read ↗

Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment AdvancementsSemantic proximity Read ↗

Impact of molecular profiling on the management of patients with myelofibrosis.Semantic proximity Read ↗

Impact of integrated genetic information on diagnosis and prognostication for myeloproliferative neoplasms in the next-generation sequencing eraSemantic proximity Read ↗

Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing EraSemantic proximity Read ↗

The role of new technologies in myeloproliferative neoplasms: Application of next-generation sequencing in myelofibrosis.Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation SequencingSemantic proximity Read ↗

Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment ResponsesSemantic proximity Read ↗

What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?Semantic proximity Read ↗

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid NeoplasmsSemantic proximity Read ↗

Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.Semantic proximity Read ↗

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaSemantic proximity Read ↗

Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.